Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study
- PMID: 12792289
- DOI: 10.1097/00042192-200310030-00004
Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study
Abstract
Objective: This study examines the effects of a dietary supplement of isoflavones on cognitive function in postmenopausal women.
Design: Participants for this 6-month, double-blind, randomized, placebo-controlled clinical trial were women who were in good health, were postmenopausal at least 2 years, and were not using estrogen replacement therapy. Between July 24, 2000, and October 31, 2000, 56 women aged 55 to 74 years were randomized; 2 in the placebo group and 1 in the active treatment group did not complete the 6-month evaluation, and none withdrew because of adverse effects. Women randomized to active treatment (n = 27) took two pills per day, each containing 55 mg of soy-extracted isoflavones (110 mg total isoflavones per day; Healthy Woman: Soy Menopause Supplement, Personal Products Company, McNeil-PPC Inc., Skillman, NJ, USA). Women assigned to placebo (n = 26) took two identical-appearing pills per day containing inert ingredients. Cognitive function tests administered at baseline and follow-up included the following: Trails A and B, category fluency, and logical memory and recall (a paragraph recall test assessing immediate and delayed verbal memory).
Results: At baseline, all women were cognitively intact; there were no significant differences by treatment assignment in age, education, depressed mood, or cognitive function (all P values > 0.10). Compliance was 98% and 97%, respectively, in the placebo and treatment groups; all women took at least 85% of their pills. The women in the treatment group did consistently better, both as compared with their own baseline scores and as compared with the placebo group responses at 6 months. Comparisons of percentage change in cognitive function between baseline and follow-up showed greater improvement in category fluency for women on active treatment as compared with the case of those on placebo (P = 0.02) and showed (nonsignificantly) greater improvement on the two other tests of verbal memory and Trails B.
Conclusion: These results suggest that isoflavone supplementation has a favorable effect on cognitive function, particularly verbal memory, in postmenopausal women.
Comment in
-
Isoflavones: food for thoughtful consideration.Menopause. 2003 May-Jun;10(3):189-90. doi: 10.1097/00042192-200310030-00001. Menopause. 2003. PMID: 12792286 No abstract available.
Similar articles
-
The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women.J Nutr Health Aging. 2007 Mar-Apr;11(2):155-64. J Nutr Health Aging. 2007. PMID: 17435957 Clinical Trial.
-
The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women.Climacteric. 2004 Mar;7(1):70-7. doi: 10.1080/13697130310001651490. Climacteric. 2004. PMID: 15259285 Clinical Trial.
-
Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.JAMA. 2004 Jul 7;292(1):65-74. doi: 10.1001/jama.292.1.65. JAMA. 2004. PMID: 15238592 Clinical Trial.
-
Soy isoflavones: hope or hype?Maturitas. 2003 Mar 14;44 Suppl 1:S21-9. doi: 10.1016/s0378-5122(02)00345-6. Maturitas. 2003. PMID: 12609556 Review.
-
Effects of herbal and dietary supplements on cognition in menopause: a systematic review.Maturitas. 2011 Mar;68(3):256-63. doi: 10.1016/j.maturitas.2010.12.005. Epub 2011 Jan 14. Maturitas. 2011. PMID: 21237589 Review.
Cited by
-
Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential.Mol Cell Biochem. 2024 Apr 3. doi: 10.1007/s11010-023-04922-w. Online ahead of print. Mol Cell Biochem. 2024. PMID: 38568359 Review.
-
Natural flavonoids as potential therapeutics in the management of Alzheimer's disease: a review.3 Biotech. 2024 Mar;14(3):68. doi: 10.1007/s13205-024-03925-8. Epub 2024 Feb 13. 3 Biotech. 2024. PMID: 38357675 Review.
-
Circuit Training Improves the Levels of β-Amyloid and Brain-Derived Neurotrophic Factor Related to Cognitive Impairment Risk Factors in Obese Elderly Korean Women.J Clin Med. 2024 Jan 30;13(3):799. doi: 10.3390/jcm13030799. J Clin Med. 2024. PMID: 38337492 Free PMC article.
-
Bioactive Compounds for Customized Brain Health: What Are We and Where Should We Be Heading?Int J Environ Res Public Health. 2023 Aug 3;20(15):6518. doi: 10.3390/ijerph20156518. Int J Environ Res Public Health. 2023. PMID: 37569058 Free PMC article. Review.
-
The Impact of Soy Isoflavone Supplementation on the Menopausal Symptoms in Perimenopausal and Postmenopausal Women.J Midlife Health. 2022 Apr-Jun;13(2):175-184. doi: 10.4103/jmh.jmh_190_21. Epub 2022 Sep 16. J Midlife Health. 2022. PMID: 36276627 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
